US 2013/0158043 A1Published application

Pak inhibitors for the treatment of cancer

AssigneeAfraxis, Inc.

InventorsDavid Campbell, Sergio G. Duron

Life of this patent

Estimating the term…

Abstract

Provided herein are methods of utilizing PAK inhibitors for the treatment of cancer. Further provided herein are compounds and formulations utilized for the treatment of cancer.

Claims20

Dependent claims

A method for treating a cell proliferative disorder in an individual in need thereof, comprising administering to the subject a therapeutically effective amount of a PAK inhibitor or a pharmaceutically acceptable salt, solvate or N-oxide thereof.

Dependencies are inferred from the claim text.

Facts

Application: 13/708,886Filed 7 Dec 2012
Priority: 9 Dec 2011
Published: 20 Jun 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 31/5377
1,4-Oxazines, e.g. morpholine: not condensed and containing further heterocyclic rings, e.g. timolol
A61K 31/541
Having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame: non-condensed thiazines containing…

Family

Application61/569,170Us provisional application · filed 9 Dec 2011
US 2013/0158043 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results